Profile
Cambridge Enterprise, the innovation arm of the University of Cambridge, is a venture investor focused on transforming university research into global impact. Based in Cambridge, UK, the organization collaborates closely with the University to commercialize research ideas through spinouts and partnerships. Their team of experienced professionals supports researchers and innovators in developing groundbreaking technologies for real-world applications.
The firm invests in a wide range of sectors including Pharmaceuticals, Biotechnology, Medical Devices, Energy, and Software, supporting ventures from early stages to commercialization. Based on the university's research landscape, they focus on the UK, with potential reach into European markets. Through its collaboration with the University of Cambridge, Cambridge Enterprise manages various investment funds but specific fund details are not provided.
Notable portfolio companies include Gigaton - autonomous plants in heavy industries, Houdini Bio - gene therapy solutions, and companies advancing universal vaccine technology. They significantly support Cambridge's startup ecosystem by providing access to talent, capital, and strategic opportunities in the university and beyond.
Industry
Cambridge Enterprise Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
University of Cambridge Enterprise Fund X
|
Venture Capital (VC)
|
Hardware
AI
MedTech
Life Sciences
Energy
CleanTech
|
Seed
Series A
|
Europe
|
$5-10 m
|
$5 M
|
September 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.